Tracers / [131I]MAAN

[131I]MAAN

Also written as [I-131]MAAN

Radionuclide: I-131 t½ 11549 min
Modality: Therapy
Production route: —
Stage: —
Syntheses indexed: 1

What it is

Compound class: —
Target / mechanism: —
Clinical application: —
Theranostic pair: —

Regulatory status

FDA: —
EMA (centralised): —
Other approvals: —
Brand names: —

Clinical use

Typical injected activity: —
Uptake time: —

Reported in the literature. Not a dosing recommendation.

Published syntheses

Module	Cassette	Purification	Yield %	RCP %	Precursor / supplier	Source
—	—	—	57.8 ± 5.3%	more than 95%	—	35297450 2022 J Mater Chem B

Need this precursor?We can point you to suppliers for [131I]MAAN, or handle the enquiry for you.

Get in touch

Notes

Added at stage 21 from therapy-discovered.xlsx (bulk PubMed search by isotope/therapy-type/known-agent, not individually researched yet) -- 2 articles found. Target/mechanism, clinical application, indications, approval and precursor fields still need per-agent research and are intentionally left empty.